Editorial
Dobutamine Stress Myocardial Perfusion Imaging: Expect the Unexpected
Abstract
Dobutamine stress myocardial perfusion imaging (DSMPI) is a pharmacologic stress test in combination with radionuclide myocardial perfusion imaging. DSMPI is the alternative method for evaluation of patients with known or suspected coronary artery disease who are unable to perform adequate exercise testing, and who also have contraindications to the vasodilators adenosine and dipyridamole pharmacologic stress testing because of severe obstructive airway disease, high-grade atrioventricular block, or marked hypotension.1,2This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Hays JT, Mahmarian JJ, Cochran AJ, et al. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583–1590.
2. Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial perfusion imaging in coronary artery disease. J Nucl Med 2002;43:1634–1646.
3. Vaidyanathan L, Anand N, Stead LG, et al. Dobutamine-Induced complete heart block. South Med J 2008;1038–1042.
4. Fung AY, Gallagher KP, Buda AG. The physiologic basis of dobutamine as compared to dipyridamole stress intervention in the assessment of critical coronary stenosis. Circulation 1987;76:943–951.
